Curaleaf Holdings Files 6-K Report

Ticker: CURLF · Form: 6-K · Filed: 2024-04-09T00:00:00.000Z

Sentiment: neutral

Topics: disclosure, regulatory-filing, foreign-private-issuer

TL;DR

Curaleaf Holdings filed a 6-K on 4/9/24, confirming 40-F reporting and including a notice of meeting.

AI Summary

Curaleaf Holdings, Inc. filed a Form 6-K on April 9, 2024, reporting information for the month of April 2024. The filing indicates that Curaleaf is a foreign private issuer and will file annual reports under Form 40-F. The report includes a signature from Peter Clateman, Chief Legal Officer, dated April 9, 2024, and an exhibit index listing a "Notice of Meeti".

Why It Matters

This filing provides routine updates and disclosures required for foreign private issuers, offering transparency to investors regarding the company's reporting status and administrative actions.

Risk Assessment

Risk Level: low — This is a routine administrative filing (6-K) and does not contain significant new financial or operational information that would typically impact risk.

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing by Curaleaf Holdings, Inc.?

The primary purpose of this Form 6-K filing is to report information for the month of April 2024 as required for a foreign private issuer, including confirmation of their annual report filing status (Form 40-F).

Who signed this Form 6-K filing on behalf of Curaleaf Holdings, Inc.?

Peter Clateman, Chief Legal Officer, signed the Form 6-K filing on behalf of Curaleaf Holdings, Inc.

On what date was this Form 6-K filed with the SEC?

This Form 6-K was filed with the SEC on April 9, 2024.

Does Curaleaf Holdings, Inc. file annual reports under Form 20-F or Form 40-F?

Curaleaf Holdings, Inc. indicated that it files annual reports under Form 40-F.

What exhibits are listed in this filing?

The filing lists Exhibit 99.1 as a 'Notice of Meeti'.

From the Filing

0001756770-24-000025.txt : 20240409 0001756770-24-000025.hdr.sgml : 20240409 20240409165716 ACCESSION NUMBER: 0001756770-24-000025 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20240409 FILED AS OF DATE: 20240409 DATE AS OF CHANGE: 20240409 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Curaleaf Holdings, Inc. CENTRAL INDEX KEY: 0001756770 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-249081 FILM NUMBER: 24833371 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 781-451-0117 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: LEAD VENTURES INC. DATE OF NAME CHANGE: 20181023 6-K 1 a6-kcover040924.htm 6-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April, 2024 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☐    Form 40-F ☒ SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CURALEAF HOLDINGS, INC. (Registrant) Date: April 9, 2024 By: /s/ Peter Clateman Name: Peter Clateman Title: Chief Legal Officer EXHIBIT INDEX Exhibit Number Description 99.1 Notice of Meeting and Record Date dated April 5, 2024 EX-99.1 2 pressrelease040924.htm EX-99.1 Document April 5, 2024 Filed via SEDAR+ To All Applicable Exchanges and Securities Administrators Subject:     Curaleaf Holdings, Inc. (the "Issuer") Notice of Meeting and Record Date Dear Sir/Madam: We are pleased to confirm the following information with respect to the Issuer's upcoming meeting of securityholders: Meeting Type: Annual General Meeting Meeting Date: June 14, 2024 Record Date for Notice of Meeting: April 30, 2024 Record Date for Voting (if applicable): April 30, 2024 Beneficial Ownership Determination Date: April 30, 2024 Class of Securities Entitled to Vote: Subordinate Voting Multiple Voting ISIN: CA23126M1023 Issuer sending proxy materials directly to NOBOs: No Issuer paying for delivery to OBOs: Yes Notice and Access for Beneficial Holders: Yes Notice and Access for Registered Holders: Yes In accordance with applicable securities regulations we are filing this information with you in our capacity as agent of the Issuer. Yours truly, Odyssey Trust Company as agent for Curaleaf Holdings, Inc. GRAPHIC 3 image_0.jpg begin 644 image_0.jpg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

View on Read The Filing